captopril has been researched along with s-nitrosocaptopril in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (5.88) | 18.7374 |
| 1990's | 11 (32.35) | 18.2507 |
| 2000's | 9 (26.47) | 29.6817 |
| 2010's | 10 (29.41) | 24.3611 |
| 2020's | 2 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Park, JW | 1 |
| Cooke, JP; Han, BJ; Lee, F; Loscalzo, J; Shaffer, JE; Thomson, S | 1 |
| Andon, N; Cooke, J; Loscalzo, J; Smick, D | 1 |
| Andon, N; Cooke, JP; Loscalzo, J | 1 |
| Kinoshita, M; Kinoshita, T; Matsumoto, T; Nakae, I; Takahashi, M | 1 |
| Amano, M; Kinoshita, M; Kosaka, T; Takahashi, M | 1 |
| De la Lande, IS; Horowitz, JD; Stafford, I; Zhang, CL | 1 |
| Kinoshita, M; Matsumoto, T; Nakae, I; Takahashi, M | 1 |
| Kinoshita, M; Liu, Q; Matsumoto, T; Mitsunami, K; Nakae, I; Takahashi, M; Takaoka, A | 1 |
| Blantz, RC; Jia, L | 1 |
| Jia, BJ; Jia, L; Lin, MJ; Wang, J; Yang, XP | 1 |
| Guo, W; Jia, L; Young, X | 1 |
| Guo, W; Jia, L; Wu, CC; Young, X | 1 |
| Jia, L; Lin, M; Pei, R; Yang, X | 1 |
| Jia, L; Wong, H | 1 |
| Jia, L | 1 |
| Kankuri, E; Kotikoski, H; Vapaatalo, H | 1 |
| Gambino, A; Tsui, DY; Wanstall, JC | 2 |
| Kotikoski, H; Oksala, O; Vapaatalo, H | 1 |
| Aquart, DV; Dasgupta, TP | 1 |
| Brown, RF; Dasgupta, TP; Holder, AA; Maragh, PT | 1 |
| Diepart, C; Gallez, B; Grégoire, V; Jordan, BF; Karroum, O; Magat, J; Peeterbroeck, J | 1 |
| Chiavarino, B; Coletti, C; Crestoni, ME; Fornarini, S; Lanucara, F; Maître, P; Re, N; Scuderi, D; Sinha, RK | 1 |
| Iglesias, E; Sexto, A | 1 |
| Chen, S; Gao, Y; Jia, L; Liang, H; Lu, Y; Shao, J; Wang, J; Wang, L; Xie, J; Yu, S; Yu, T | 1 |
| Duliban, H; Król, W; Machorowska-Pieniążek, A; Mertas, A; Szliszka, E | 1 |
| Iglesias, E; Prado-Gotor, R | 1 |
| Adler, B; Clendaniel, A; da Costa Neto, AB; Friedman, AJ; Friedman, JM; Gunther, L; Harper, S; Krausz, A; Liang, H; Mordorski, B; Nacharaju, P; Nosanchuk, JD; Pelgrift, R | 1 |
| Cheng, Y; Jia, L; Lian, S; Liang, H; Lu, Y; Xie, X; Ye, Y; Yu, T | 1 |
| Chen, F; Chen, J; Chen, W; Han, L; Jia, L; Li, F; Lin, M; Shao, JW; Wang, C; Wang, J; Zhou, Y | 1 |
| Cheng, Y; Gao, Y; Jia, L; Lian, S; Liang, H; Lu, Y; Xie, J; Xie, X; Ye, Y; Yu, S; Yu, T; Zhu, Y | 1 |
| Dong, HY; Jia, L; Li, YM; Lin, M; Xie, HZ | 1 |
| Huang, L; Lin, M; Wang, Y; Zhou, Y | 1 |
1 review(s) available for captopril and s-nitrosocaptopril
| Article | Year |
|---|---|
[A design of a novel compound S-nitrosocaptopril possessing the capacities of both angiotensin converting enzyme inhibitors and NO donors].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Nitric Oxide; Nitric Oxide Donors; Vasodilator Agents | 1999 |
33 other study(ies) available for captopril and s-nitrosocaptopril
| Article | Year |
|---|---|
Dual role of S-nitrosocaptopril as an inhibitor of angiotensin-converting enzyme and a nitroso group carrier.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Glutathione; Hemoglobins; Kinetics; Spectrophotometry | 1992 |
The hemodynamic effects of S-nitrosocaptopril in anesthetized dogs.
Topics: Angiotensin I; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Dogs; Drug Tolerance; Female; Male; Nitroglycerin | 1991 |
S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cattle; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; In Vitro Techniques; Platelet Aggregation Inhibitors; Rats; Vasodilator Agents | 1989 |
S-nitrosocaptopril. II. Effects on vascular reactivity.
Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cattle; Coronary Vessels; Drug Interactions; Femoral Artery; In Vitro Techniques; Methylene Blue; Saralasin; Vasodilator Agents | 1989 |
The effects of S-nitrosocaptopril on canine coronary circulation.
Topics: Animals; Captopril; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Male; Vasodilator Agents | 1995 |
Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide.
Topics: Adult; Aged; Blood Platelets; Calcium; Captopril; Female; Humans; In Vitro Techniques; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Nitroso Compounds; Platelet Aggregation; Platelet Aggregation Inhibitors; Serum Albumin, Bovine; Vasodilator Agents | 1994 |
S-nitrosothiol modulation of tolerance to glyceryl trinitrate in bovine isolated coronary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Captopril; Cattle; Coronary Vessels; Dose-Response Relationship, Drug; Drug Tolerance; In Vitro Techniques; Nitroglycerin; Nitroso Compounds; Penicillamine; Prostaglandin Endoperoxides, Synthetic; S-Nitroso-N-Acetylpenicillamine; Thromboxane A2; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1994 |
Vasorelaxing effect of S-nitrosocaptopril on dog coronary arteries: no cross-tolerance with nitroglycerin.
Topics: Animals; Arteries; Captopril; Coronary Vessels; Cyclic GMP; Dogs; Drug Interactions; Drug Tolerance; Female; In Vitro Techniques; Male; Nitric Oxide; Nitroglycerin; Nitroprusside; Vasodilator Agents | 1995 |
No cross-tolerance between S-nitrosocaptopril and nitroglycerin in dog coronary arteries in vivo.
Topics: Aldosterone; Animals; Captopril; Coronary Circulation; Cyclic GMP; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Drug Tolerance; Female; Hemodynamics; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Nitrates; Nitric Oxide; Nitroglycerin; Norepinephrine; Peptidyl-Dipeptidase A; Renin; Vasodilator Agents | 1998 |
The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Glomerular Filtration Rate; Hypertension, Renovascular; Injections, Intravenous; Kidney; Male; Nitric Oxide Donors; Rats; Rats, Wistar; Vasodilator Agents | 1998 |
Inhibitory effects of S-nitrosocaptopril on vasomotor tone.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Arginine; Captopril; Endothelium, Vascular; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phenylephrine; Rabbits; Rats; Rats, Sprague-Dawley; Renal Circulation; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 1998 |
Physicochemistry, pharmacokinetics, and pharmacodynamics of S-nitrosocaptopril crystals, a new nitric oxide donor.
Topics: Animals; Antihypertensive Agents; Captopril; Chemical Phenomena; Chemistry, Physical; Chromatography, Thin Layer; Crystallization; Feces; Magnetic Resonance Spectroscopy; Male; Nitric Oxide Donors; Rats; Rats, Inbred SHR; Spectrophotometry, Ultraviolet; Tissue Distribution | 1999 |
Antiangiogenic effects of S-nitrosocaptopril crystals as a nitric oxide donor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Captopril; Cell Division; Chick Embryo; Chorion; Crystallization; Endothelium, Vascular; Hemoglobins; Male; Membranes; Neovascularization, Physiologic; Nitric Oxide Donors; Rats; Rats, Wistar; Spectrophotometry, Ultraviolet; X-Ray Diffraction | 2000 |
Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cause of Death; Drug Evaluation, Preclinical; Energy Intake; Female; Growth; Hypertension; Hypotension; Injections, Intravenous; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Nitric Oxide Donors; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Toxicity Tests; Toxicity Tests, Acute; Treatment Outcome; Vasodilator Agents | 2001 |
In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S-nitrosylated captopril, a nitric oxide donor.
Topics: Animals; Aorta; Biological Transport; Blood Pressure; Caco-2 Cells; Captopril; Cell Membrane Permeability; Cells, Cultured; Coronary Circulation; Coronary Vessels; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Hemodynamics; Humans; Infant, Newborn; Injections, Intravenous; Nitric Oxide Donors; Pharmaceutical Preparations; Rats; Regional Blood Flow; Telencephalon; Umbilical Veins | 2001 |
Incubation of porcine iris-ciliary bodies to study the mechanisms by which nitric oxide donors lower intraocular pressure.
Topics: Animals; Captopril; Ciliary Body; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Guanylate Cyclase; Intraocular Pressure; Iris; Nitrates; Nitric Oxide; Nitric Oxide Donors; Nitrites; Nitro Compounds; Nitrogen Oxides; Oxadiazoles; Penicillamine; Phosphodiesterase Inhibitors; Purinones; Quinoxalines; Rabbits; S-Nitrosothiols; Spermine; Swine; Time Factors | 2003 |
S-nitrosocaptopril: in vitro characterization of pulmonary vascular effects in rats.
Topics: Animals; Captopril; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Pulmonary Artery; Rats; Rats, Wistar; Vasoconstriction | 2003 |
Nitric oxide and cyclic GMP enhance aqueous humor outflow facility in rabbits.
Topics: Animals; Anterior Chamber; Aqueous Humor; Captopril; Cyclic GMP; Female; Intraocular Pressure; Male; Nitric Oxide; Nitroprusside; Rabbits | 2003 |
S-nitrosocaptopril: acute in-vivo pulmonary vasodepressor effects in pulmonary hypertensive rats.
Topics: Administration, Oral; Animals; Captopril; Disease Models, Animal; Hypertension, Pulmonary; Hypoxia; Injections, Intravenous; Lung; Male; Rats; Rats, Wistar; Time Factors; Vasoconstrictor Agents; Vasodilation | 2003 |
Dynamics of interaction of vitamin C with some potent nitrovasodilators, S-nitroso-N-acetyl-d,l-penicillamine (SNAP) and S-nitrosocaptopril (SNOCap), in aqueous solution.
Topics: Ascorbic Acid; Captopril; Catalysis; Copper; Edetic Acid; Hydrogen-Ion Concentration; Kinetics; Nitric Oxide; Osmolar Concentration; Penicillamine; S-Nitrosothiols; Sodium Chloride; Solutions; Vasodilator Agents | 2004 |
Dynamic studies of transnitrosation of thiols of biological importance by the nitrosated 4,4',4'',4'''-tetrasulfophthalocyaninecobaltate(III) anion in aqueous solution.
Topics: Captopril; Chromatography, High Pressure Liquid; Kinetics; Mass Spectrometry; Nitrosation; Organometallic Compounds; Structure-Activity Relationship; Sulfhydryl Compounds; Temperature; Water | 2009 |
Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Hemodynamics; Liver Neoplasms, Experimental; Male; Mice; Neoplasm Transplantation; Nitric Oxide; Oxygen Consumption; Radiation Tolerance; Vasodilator Agents | 2010 |
IRMPD spectroscopy of protonated S-nitrosocaptopril, a biologically active, synthetic amino acid.
Topics: Amides; Amino Acids; Captopril; Isomerism; Protons; Spectrophotometry, Infrared; Thermodynamics | 2010 |
S-nitrosocaptopril formation in aqueous acid and basic medium. A vasodilator and angiotensin converting enzyme inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Hydrogen-Ion Concentration; Micelles; Molecular Structure; Nitric Oxide; Vasodilator Agents | 2011 |
Nitric oxide inhibits hetero-adhesion of cancer cells to endothelial cells: restraining circulating tumor cells from initiating metastatic cascade.
Topics: Captopril; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Survival; Cytokines; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression; Guanylate Cyclase; Hemoglobins; Human Umbilical Vein Endothelial Cells; Humans; Neoplasm Metastasis; Neoplastic Cells, Circulating; Nitric Oxide; Nitric Oxide Donors; Vascular Cell Adhesion Molecule-1; Vasodilation | 2014 |
N-[3-(aminomethyl)benzyl]acetamidine (1400 W) as a potential immunomodulatory agent.
Topics: Animals; Captopril; Cell Line; Enzyme Inhibitors; Imines; Immunologic Factors; Interleukin-12; L-Lactate Dehydrogenase; Macrophage Activation; Macrophages; Mice; Nitric Oxide Synthase; Nitrites; Tumor Necrosis Factor-alpha | 2014 |
Interaction of gold nanoparticles mediated by captopril and S-nitrosocaptopril: the effect of manganese ions in mild acid medium.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Cations, Divalent; Citric Acid; Cysteine; Gold; Manganese; Metal Nanoparticles; Sulfhydryl Compounds; Surface Plasmon Resonance | 2015 |
S-nitrosocaptopril nanoparticles as nitric oxide-liberating and transnitrosylating anti-infective technology.
Topics: Anti-Infective Agents; Captopril; Escherichia coli; Glutathione; Humans; Immune System; Methicillin-Resistant Staphylococcus aureus; Nanoparticles; Nitric Oxide; Staphylococcal Infections | 2015 |
S-nitrosocaptopril interrupts adhesion of cancer cells to vascular endothelium by suppressing cell adhesion molecules via inhibition of the NF-кB and JAK/STAT signal pathways in endothelial cells.
Topics: Animals; Captopril; Cell Adhesion; Cell Adhesion Molecules; Cytokines; Drug Synergism; Endothelium, Vascular; Gene Expression Regulation, Neoplastic; HT29 Cells; Human Umbilical Vein Endothelial Cells; Humans; Janus Kinases; Neoplasm Metastasis; NF-kappa B; Safety; Signal Transduction; STAT Transcription Factors; Time Factors | 2016 |
A novel S-nitrosocaptopril monohydrate for pulmonary arterial hypertension: H
Topics: Animals; Antihypertensive Agents; Aorta; Captopril; Crystallization; Disease Models, Animal; Endothelium, Vascular; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Nitric Oxide Donors; Rats; Rats, Sprague-Dawley; Sodium Nitrite; Stomach; Tissue Culture Techniques; Vascular Resistance; Vasodilation; Vasodilator Agents | 2018 |
S-Nitrosocaptopril prevents cancer metastasis in vivo by creating the hostile bloodstream microenvironment against circulating tumor cells.
Topics: Animals; Antineoplastic Agents; Blood Platelets; Captopril; Cell Adhesion; Cell Line, Tumor; Female; Human Umbilical Vein Endothelial Cells; Humans; Male; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Neoplastic Cells, Circulating; P-Selectin; Platelet Glycoprotein GPIIb-IIIa Complex | 2019 |
Why do we lack a specific magic anti-COVID-19 drug? Analyses and solutions.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Captopril; Cardiovascular System; COVID-19; COVID-19 Drug Treatment; Drug Development; Drug Repositioning; Humans; Nebulizers and Vaporizers; Pharmaceutical Preparations; Respiratory System; SARS-CoV-2; Treatment Outcome | 2021 |
Optimization of S-Nitrosocaptopril Monohydrate Storage Conditions Based on Response Surface Method.
Topics: Angiotensin-Converting Enzyme Inhibitors; Captopril; Nitric Oxide Donors; Vasodilator Agents | 2021 |